Emerging Diagnostic Imaging Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
The emerging diagnostic imaging market is segmented on the basis of applications such as advanced conventional technologies, remote diagnostics, point-of-care diagnostics, nuclear medicine, biomarkers, imaging agents and other emerging technologies. The report includes emerging technologies which are commercialized and which are going through final phases of approvals. Market covered in the emerging diagnostic imaging are North America, Latin America, Europe, Middle-East and Africa (MEA) and Asia-Pacific.
The diagnostic equipment of conventional technologies are over burdened with the hospitals and diagnostic centers having limited resources and budgets, especially in emerging markets like India and China. Hence there is requirement of machines that are capable of performing multiple diagnoses. Portable diagnostic machines are one of the major advancement which enables providing point-of-care assistance and reaching out to more number of patients.
United States being the largest healthcare market is number one in making changes so that healthcare can become more affordable to people. There is an increase in demand of services as well as products that are value based in the industry that lacks resources as well as skills. Opportunities are growing for the industry with the emergence of new markets. They are situated in the developing economies with ever changing needs.
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
The diagnostic equipment of conventional technologies are over burdened with the hospitals and diagnostic centers having limited resources and budgets, especially in emerging markets like India and China. Hence there is requirement of machines that are capable of performing multiple diagnoses. Portable diagnostic machines are one of the major advancement which enables providing point-of-care assistance and reaching out to more number of patients.
United States being the largest healthcare market is number one in making changes so that healthcare can become more affordable to people. There is an increase in demand of services as well as products that are value based in the industry that lacks resources as well as skills. Opportunities are growing for the industry with the emergence of new markets. They are situated in the developing economies with ever changing needs.
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
CHAP 1. EXECUTIVE SUMMARY
CHAP 2. KEY FINDINGS
2.1. Finding 1: What is the need of hour for med imaging cos? – Patient care/Innovations/Cost/
Novel Business Model?
2.2. Finding 2: How are regulations to affect the future market?
2.3. Finding 3: Brown Water Strategy – Understanding Regional Markets
CHAP 3. SECTOR ANALYSIS: MEDICAL DEVICES MARKET
3.1. Orientation to Diagnostic Imaging Systems
CHAP 4. REGULATORY IMPLICATIONS
4.1. INTRODUCTION
4.1.1. Europe
4.1.1.1. ROHS II
4.1.2. U.S.
4.1.2.1. Class I devices
4.1.2.2. Class II devices
4.1.2.3. Class III devices
4.2. China
4.2.1. Japan
4.2.2. India
4.2.3. Indonesia
4.2.4. Korea
4.2.5. Malaysia
4.2.6. The Philippines
4.2.7. Singapore
4.2.8. Taiwan
4.2.9. Australia
4.2.10. Hong Kong
4.2.11. Vietnam
CHAP 5. MARKET DETERMINANTS
5.1. Market Drivers
5.1.1. Aging population- A global issue to boost the need for diagnostics
5.1.2. Increase in lifestyle and chronic diseases
5.1.3. Other drivers include:
5.1.3.1. Limitations and Restrictions
5.1.3.2. Some other restrictive factors that are likely to impact the industry negatively are:
5.1.4. Opportunities
CHAP 6. DIAGNOSTIC IMAGING DEVICES MARKET
6.1. Magnetic Imaging Resonance (MRI) System
6.2. Rest of World
6.2.1. Market Dynamics
6.2.2. Competitive Intelligence & Key Strategies
6.2.2.1. GE Healthcare
6.2.2.2. Toshiba
6.2.2.3. Siemens
6.2.2.4. Hitachi
6.2.2.5. Philips
6.2.3. Market Share of Key Companies, 2012
6.2.4. Market Trends and Determinants
6.2.5. Geographic Analysis
6.2.5.1. Ultrasound Technologies Market
6.2.6. Market Trends and Determinants
6.2.7. Competitive Intelligence & Key Strategies
6.2.8. Geographic Analysis
6.2.9. Laser Imaging Market
6.2.10. Market Determinants
6.2.11. Competitive Intelligence and Key Strategies
6.2.12. Company Market Share, 2012
6.2.13. Geographic Analysis
6.2.13.1. Interventional Radiology Market
6.2.14. Market Trends and Determinants
6.2.15. Competitive intelligence and Key strategies
6.2.16. Geographic Analysis
6.2.16.1. X-ray
6.2.17. Market determinants
6.2.18. Competitive Intelligence & key Strategies
6.2.19. Market share of key players, 2012
6.2.20. Geographic Analysis
6.2.20.1. Nuclear Medicine
6.2.21. Market determinants
6.2.22. Competitive Intelligence & Key Strategies
6.2.23. Market share of key players, 2012
6.2.24. Geographic Analysis
CHAP 7. GEOGRAPHY ANALYSIS
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.2.1. Europe
7.1.3. Enabling people to live healthy and productive lives
7.1.4. Increasing the productivity and efficiency of healthcare systems
7.1.5. Contributing to economic growth
7.1.5.1. Benefits of the EU regulatory system in access to novel technologies
7.2. Asia
7.2.1. Population Size
7.2.2. Economics
7.2.3. Aging Populations
7.2.3.1. Asia's Growing Market for Cardiovascular Devices
7.2.4. RAPIDLY GROWING DEMAND
7.2.5. Each country in Asia has different medical device regulations and classifications,
usually based on the level of risk to the patient.
7.2.5.1. Outsourcing Medical Devices to Asia: Trends and Tips
7.2.6. Conclusion
7.2.7. Increased Medical Device Regulations for Asia's New Tigers
7.2.8. China
7.2.8.1. Understanding the China Medical Device Market
7.2.8.2. China Regulatory Agency for Medical Devices
7.2.8.3. Major healthcare issues for China to tackle include
7.2.8.4. Healthcare Development in Rural and Urban Areas
7.2.8.5. Greater Private-Sector Opportunities
7.2.8.6. More Affordable Healthcare
7.2.8.7. Tighter Medical Device Regulations
7.2.8.8. The Battle Over China's Medical Device Market 2013
7.2.9. India
7.2.10. Japan
7.2.11. Korea
7.2.12. MALAYSIA
7.2.12.1. The Medical Device Act
7.2.12.2. The Medical Device Authority Act
7.2.13. INDONESIA
7.2.13.1. Infrastructure growth4
7.2.13.2. Online registration system
7.2.14. THAILAND
7.2.15. VIETNAM
7.2.16. SINGAPORE
7.2.17. South Korea
7.2.17.1. Rest of The World
7.2.18. Turkey
7.2.19. Iran
7.2.20. Brazil
CHAP 8. COMPANY PROFILES
8.1. LUMENIS LTD.
8.2. BIOLASE
8.3. PHOTOMEDEX
8.4. IRIDEX CORPORATION
8.5. SPECTRANETICS CORPORATION
8.6. GE HEALTHCARE
8.7. SIEMENS HEALTHCARE
8.8. PHILIPS HEALTHCARE
8.9. ABBOTT LABORATORIES
8.10. AGILENT TECHNOLOGIES
8.11. BIO RAD LABORATORIES
8.12. BRACCO IMAGING
8.13. CARDINAL HEALTH
8.14. COVIDIEN PLC
CHAP 2. KEY FINDINGS
2.1. Finding 1: What is the need of hour for med imaging cos? – Patient care/Innovations/Cost/
Novel Business Model?
2.2. Finding 2: How are regulations to affect the future market?
2.3. Finding 3: Brown Water Strategy – Understanding Regional Markets
CHAP 3. SECTOR ANALYSIS: MEDICAL DEVICES MARKET
3.1. Orientation to Diagnostic Imaging Systems
CHAP 4. REGULATORY IMPLICATIONS
4.1. INTRODUCTION
4.1.1. Europe
4.1.1.1. ROHS II
4.1.2. U.S.
4.1.2.1. Class I devices
4.1.2.2. Class II devices
4.1.2.3. Class III devices
4.2. China
4.2.1. Japan
4.2.2. India
4.2.3. Indonesia
4.2.4. Korea
4.2.5. Malaysia
4.2.6. The Philippines
4.2.7. Singapore
4.2.8. Taiwan
4.2.9. Australia
4.2.10. Hong Kong
4.2.11. Vietnam
CHAP 5. MARKET DETERMINANTS
5.1. Market Drivers
5.1.1. Aging population- A global issue to boost the need for diagnostics
5.1.2. Increase in lifestyle and chronic diseases
5.1.3. Other drivers include:
5.1.3.1. Limitations and Restrictions
5.1.3.2. Some other restrictive factors that are likely to impact the industry negatively are:
5.1.4. Opportunities
CHAP 6. DIAGNOSTIC IMAGING DEVICES MARKET
6.1. Magnetic Imaging Resonance (MRI) System
6.2. Rest of World
6.2.1. Market Dynamics
6.2.2. Competitive Intelligence & Key Strategies
6.2.2.1. GE Healthcare
6.2.2.2. Toshiba
6.2.2.3. Siemens
6.2.2.4. Hitachi
6.2.2.5. Philips
6.2.3. Market Share of Key Companies, 2012
6.2.4. Market Trends and Determinants
6.2.5. Geographic Analysis
6.2.5.1. Ultrasound Technologies Market
6.2.6. Market Trends and Determinants
6.2.7. Competitive Intelligence & Key Strategies
6.2.8. Geographic Analysis
6.2.9. Laser Imaging Market
6.2.10. Market Determinants
6.2.11. Competitive Intelligence and Key Strategies
6.2.12. Company Market Share, 2012
6.2.13. Geographic Analysis
6.2.13.1. Interventional Radiology Market
6.2.14. Market Trends and Determinants
6.2.15. Competitive intelligence and Key strategies
6.2.16. Geographic Analysis
6.2.16.1. X-ray
6.2.17. Market determinants
6.2.18. Competitive Intelligence & key Strategies
6.2.19. Market share of key players, 2012
6.2.20. Geographic Analysis
6.2.20.1. Nuclear Medicine
6.2.21. Market determinants
6.2.22. Competitive Intelligence & Key Strategies
6.2.23. Market share of key players, 2012
6.2.24. Geographic Analysis
CHAP 7. GEOGRAPHY ANALYSIS
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.2.1. Europe
7.1.3. Enabling people to live healthy and productive lives
7.1.4. Increasing the productivity and efficiency of healthcare systems
7.1.5. Contributing to economic growth
7.1.5.1. Benefits of the EU regulatory system in access to novel technologies
7.2. Asia
7.2.1. Population Size
7.2.2. Economics
7.2.3. Aging Populations
7.2.3.1. Asia's Growing Market for Cardiovascular Devices
7.2.4. RAPIDLY GROWING DEMAND
7.2.5. Each country in Asia has different medical device regulations and classifications,
usually based on the level of risk to the patient.
7.2.5.1. Outsourcing Medical Devices to Asia: Trends and Tips
7.2.6. Conclusion
7.2.7. Increased Medical Device Regulations for Asia's New Tigers
7.2.8. China
7.2.8.1. Understanding the China Medical Device Market
7.2.8.2. China Regulatory Agency for Medical Devices
7.2.8.3. Major healthcare issues for China to tackle include
7.2.8.4. Healthcare Development in Rural and Urban Areas
7.2.8.5. Greater Private-Sector Opportunities
7.2.8.6. More Affordable Healthcare
7.2.8.7. Tighter Medical Device Regulations
7.2.8.8. The Battle Over China's Medical Device Market 2013
7.2.9. India
7.2.10. Japan
7.2.11. Korea
7.2.12. MALAYSIA
7.2.12.1. The Medical Device Act
7.2.12.2. The Medical Device Authority Act
7.2.13. INDONESIA
7.2.13.1. Infrastructure growth4
7.2.13.2. Online registration system
7.2.14. THAILAND
7.2.15. VIETNAM
7.2.16. SINGAPORE
7.2.17. South Korea
7.2.17.1. Rest of The World
7.2.18. Turkey
7.2.19. Iran
7.2.20. Brazil
CHAP 8. COMPANY PROFILES
8.1. LUMENIS LTD.
8.2. BIOLASE
8.3. PHOTOMEDEX
8.4. IRIDEX CORPORATION
8.5. SPECTRANETICS CORPORATION
8.6. GE HEALTHCARE
8.7. SIEMENS HEALTHCARE
8.8. PHILIPS HEALTHCARE
8.9. ABBOTT LABORATORIES
8.10. AGILENT TECHNOLOGIES
8.11. BIO RAD LABORATORIES
8.12. BRACCO IMAGING
8.13. CARDINAL HEALTH
8.14. COVIDIEN PLC
LIST OF TABLES
1 GLOBAL MARKET FOR DIAGNOSTIC IMAGING DEVICES 2014-2022 ($ MILLION)
2 GLOBAL MEDICAL DEVICES MARKET, 2012 THROUGH 2018, $BILLION
3 DIAGNOSTIC IMAGING MARKET BY PRODUCTS 2012 THROUGH 2018 $MILLIONS
4 NO. OF PEOPLE WITH DIABETES FROM 2010 TO 2030
5 GLOBAL MRI MARKET BY GEOGRAPHIES, 2012 THROUGH 2018, IN MILLIONS
6 ULTRASOUND TECHNOLOGIES MARKET BY GEOGRAPHIES, 2012 THROUGH 2018, IN $MILLIONS
7 LASER IMAGING MARKET BY GEOGRAPHIES 2014-2022 ($ MILLION)
8 INTERVENTIONAL RADIOLOGY MARKET, BY GEOGRAPHIES 2014-2022 ($ MILLION)
9 8 X-RAY MARKET, BY GEOGRAPHY 2014-2022 ($ MILLION)
10 NUCLEAR MEDICINE MARKET, BY GEOGRAPHY 2014-2022 ($ MILLION)
11 REIMBURSEMENT POLICIES LAID OUT BY THE CENTERS FOR MEDICARE AND MEDICAID SERVICES IN THE U.S.
12 NORTH AMERICA MARKET FOR IMAGING DEVICES 2014-2022 ($ MILLION)
13 EUROPE IMAGING DEVICES MARKET 2014-2022 ($ MILLION)
14 ASIAN MARKET FOR IMAGING DEVICES 2014-2022 ($ MILLION)
15 MARKET FOR SOUTH AMERICA 2014-2022 ($ MILLION)
16 MARKET FOR REST OF WORLD 2014-2022 ($ MILLION)
1 GLOBAL MARKET FOR DIAGNOSTIC IMAGING DEVICES 2014-2022 ($ MILLION)
2 GLOBAL MEDICAL DEVICES MARKET, 2012 THROUGH 2018, $BILLION
3 DIAGNOSTIC IMAGING MARKET BY PRODUCTS 2012 THROUGH 2018 $MILLIONS
4 NO. OF PEOPLE WITH DIABETES FROM 2010 TO 2030
5 GLOBAL MRI MARKET BY GEOGRAPHIES, 2012 THROUGH 2018, IN MILLIONS
6 ULTRASOUND TECHNOLOGIES MARKET BY GEOGRAPHIES, 2012 THROUGH 2018, IN $MILLIONS
7 LASER IMAGING MARKET BY GEOGRAPHIES 2014-2022 ($ MILLION)
8 INTERVENTIONAL RADIOLOGY MARKET, BY GEOGRAPHIES 2014-2022 ($ MILLION)
9 8 X-RAY MARKET, BY GEOGRAPHY 2014-2022 ($ MILLION)
10 NUCLEAR MEDICINE MARKET, BY GEOGRAPHY 2014-2022 ($ MILLION)
11 REIMBURSEMENT POLICIES LAID OUT BY THE CENTERS FOR MEDICARE AND MEDICAID SERVICES IN THE U.S.
12 NORTH AMERICA MARKET FOR IMAGING DEVICES 2014-2022 ($ MILLION)
13 EUROPE IMAGING DEVICES MARKET 2014-2022 ($ MILLION)
14 ASIAN MARKET FOR IMAGING DEVICES 2014-2022 ($ MILLION)
15 MARKET FOR SOUTH AMERICA 2014-2022 ($ MILLION)
16 MARKET FOR REST OF WORLD 2014-2022 ($ MILLION)
LIST OF FIGURES
4 GROWTH OF DIABETICS ACROSS THE WORLD: COMPARATIVE PREVALENCE (%) OF DIABETES AND IGT
5 NUMBER OF PEOPLE WITH DIABETES (MILLIONS)
6 WORLDWIDE PATIENTS WITH CHRONIC DISEASES, 2005–2030
9 TOP 10 COUNTRIES WITH THE EXPECTED HIGHEST SHARE OF 60+ POPULATIONS, 2050
11 GLOBAL ALZHEIMER PREVALENCE, 2010-2050 (MILLION)
15 PACS IMPLEMENTATION PROCESS
16 GLOBAL PERCENTAGE OF POPULATION, BY AGE-GROUP
COMPANIES MENTIONED
1. LUMENIS LTD.
2. BIOLASE
3. PHOTOMEDEX
4. IRIDEX CORPORATION
5. SPECTRANETICS CORPORATION
6. GE HEALTHCARE
7. SIEMENS HEALTHCARE
8. PHILIPS HEALTHCARE
9. ABBOTT LABORATORIES
10. AGILENT TECHNOLOGIES
11. BIO RAD LABORATORIES
12. BRACCO IMAGING
13. CARDINAL HEALTH
14. COVIDIEN PLC
4 GROWTH OF DIABETICS ACROSS THE WORLD: COMPARATIVE PREVALENCE (%) OF DIABETES AND IGT
5 NUMBER OF PEOPLE WITH DIABETES (MILLIONS)
6 WORLDWIDE PATIENTS WITH CHRONIC DISEASES, 2005–2030
9 TOP 10 COUNTRIES WITH THE EXPECTED HIGHEST SHARE OF 60+ POPULATIONS, 2050
11 GLOBAL ALZHEIMER PREVALENCE, 2010-2050 (MILLION)
15 PACS IMPLEMENTATION PROCESS
16 GLOBAL PERCENTAGE OF POPULATION, BY AGE-GROUP
COMPANIES MENTIONED
1. LUMENIS LTD.
2. BIOLASE
3. PHOTOMEDEX
4. IRIDEX CORPORATION
5. SPECTRANETICS CORPORATION
6. GE HEALTHCARE
7. SIEMENS HEALTHCARE
8. PHILIPS HEALTHCARE
9. ABBOTT LABORATORIES
10. AGILENT TECHNOLOGIES
11. BIO RAD LABORATORIES
12. BRACCO IMAGING
13. CARDINAL HEALTH
14. COVIDIEN PLC
